paroxetine has been researched along with Attention Deficit and Disruptive Behavior Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asarnow, JR; Birmaher, B; Brent, DA; Clarke, GN; Emslie, GJ; He, J; Hilton, RC; Keller, MB; Mansoor, B; Mayes, T; Porta, G; Rengasamy, M; Ryan, N; Shamseddeen, W; Wagner, KD | 1 |
Buitelaar, JK; Lahuis, B; Vorstman, J | 1 |
1 trial(s) available for paroxetine and Attention Deficit and Disruptive Behavior Disorders
Article | Year |
---|---|
Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Topics: Adolescent; Anxiety; Attention Deficit and Disruptive Behavior Disorders; Behavioral Symptoms; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Fluoxetine; Humans; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
1 other study(ies) available for paroxetine and Attention Deficit and Disruptive Behavior Disorders
Article | Year |
---|---|
SSRIs associated with behavioral activation and suicidal ideation.
Topics: Attention Deficit and Disruptive Behavior Disorders; Child; Depressive Disorder, Major; Fluvoxamine; Humans; Male; Paroxetine; Suicide, Attempted | 2001 |